Evaluation of biological pathways involved in chemotherapy response in breast cancer

April 29th, 2008 by admin

IntroductionOur content was to investigate the connexion between natural pathways and salutation to chemotherapy in oestrogen organ (ER)-positive and ER-negative boob cancers separately.
Methods:
Gene ordered enrichment psychotherapy including 852 predefined factor sets, was practical to factor countenance accumulation from 51 ER-negative and 82 ER-positive boob cancers that were every aerated with a preoperative paclitaxel, 5-fluoruracil, doxorubicin and cyclophosphamide chemotherapy.
Results:
Twenty-seven (53%) ER-negative and 7 (9%) ER-positive patients had pathologic rank salutation (pCR) to therapy. Among the ER-negative cancers, a proliferation factor mode (FDR q=0.1), the Genomic Grade Index (FDR q =0.044) and the E2F3 path (FDR q =0.22, p=0.07) mode were enriched in the pCR group. Among the ER-positive cancers, the proliferation mode (FDR q =0.001) and the Genomic Grade Index (FDR q =0.015) were also significantly enriched in cases with pCR. Ki67 expression, as azygos factor symbol of proliferation, did not wage the aforementioned aggregation as the whole proliferation signature. An ER-associated factor ordered (FDR q = 0.03) and a organism p53-gene mode (FDR q = 0.0019) were enriched in ER-positive cancers with matter cancer.
Conclusion:
Proliferation- and genomic grade-related factor signatures are related with chemotherapy sense in both ER-negative and -positive boob cancers. Genes participating in the E2F3 path are related with chemotherapy sense among ER-negative cancers. The organism p53-signature and countenance of ER-related genes were related with modify sense to chemotherapy in ER-positive boob cancers only.

Tags: , , , , , ,

Posted in Cancer |

Related posts

Comments are closed.